What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?

(MedPage Today) -- Lung cancer, particularly non-small cell lung cancer (NSCLC), remains a significant clinical challenge due to its aggressive nature and resistance to conventional therapies.
The advent of cancer immunotherapy (CIT) has provided...